MR编号 | DE/H/6270/002 |
---|
药品名称 | Enoxaparin Ledraxen 8.000 IE (80 mg)/0,8 ml Injektionslösung in einer Fertigspritze |
---|
活性成分 | - enoxaparin sodium 8000.0 anti-Xa IU/0.8
|
---|
剂型 | Solution for injection in pre-filled syringe |
---|
上市许可持有人 | Venipharm
4 Bureaux de la Colline
92210 Saint-Cloud
France |
---|
参考成员国 - 产品名称 | Germany (DE) |
---|
互认成员国 - 产品名称 | - Czechia (CZ)
Enoxaparin Ledraxen - Ireland (IE)
- France (FR)
- Slovakia (SK)
- Austria (AT)
- Croatia (HR)
- Portugal (PT)
- Slovenia (SI)
- Norway (NO)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
Enoxaparin sodium Ledraxen 8000 TV (80 mg)/0,8 ml injekcinis tirpalas užpildytame švirkšte - United Kingdom (Northern Ireland) (XI)
- Spain (ES)
- Sweden (SE)
- Estonia (EE)
- Cyprus (CY)
Enoxaparin Ledraxen 8.000 IE (80 mg)/0,8 ml solution for injection in pre-filled syringe
|
---|
许可日期 | 2019/02/11 |
---|
最近更新日期 | 2024/05/23 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|